Thermo Fisher Launches HepatoExpress Kit for Liver Cell Gene Expression Analysis
New kit cuts sample-to-result time to 75 minutes while maintaining sensitivity for drug metabolism studies.
New kit cuts sample-to-result time to 75 minutes while maintaining sensitivity for drug metabolism studies.
The platform features enhanced speed and digital connectivity for liquid biopsy applications, with commercial release planned for mid-2026.
The new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Multi-omics study reveals psychiatric comorbidities in bladder pain syndrome patients while demonstrating advantages in hematological malignancies and repeat expansion analysis.
Read MoreSPRQ-Nx chemistry for Revio and Vega platforms is designed to reduce sequencing expenses by up to 40% while adding multiomic capabilities.
Read MoreThe machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MoreA novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read MoreA study of 1,000 newborns found that genomic testing could identify hundreds of additional childhood conditions using the same blood sample from a heel-prick test.
Read MoreThe optimized protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kit for clinical research and precision medicine applications.
Read MoreWasatch BioLabs expands service portfolio with pharmacogenomics panel, telomere sequencing, and mRNA vaccine quality control workflows.
Read MoreNew materials aim to help patients and providers understand emerging molecular diagnostic tools for hypertensive disorders of pregnancy.
Read MoreBEACONS, a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in US newborn screening.
Read MoreThe companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Read MoreNew research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read MoreThe French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read MoreThe collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read MoreThe collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.
Read MoreThe program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.
Read More